China NMPA Product Recall - Knee components

On November 7, 2018, the National Medical Products Administration (NMPA) published details of a voluntary Class II recall initiated by Biomet Orthopedics, reported by Zimmer Medical (Shanghai) International Trading Co., Ltd. The recall, with a report date of October 26, 2018, concerns specific knee joint components (National Medical Device Registration Certificate 20173460467). The primary issue identified was an error in product packaging labeling, where patient labels did not match the labels on the inner sterile packaging, leading to a potential packaging mixing risk. This specifically impacted PS Open-Box Femoral Condyle Prosthesis - Right, 65mm, and other components. Although these affected batches were primarily distributed in regions like the United States and South Korea and were not sold in China, the company has taken proactive steps to address the identified labeling discrepancy for its Vanguard knee systems. The regulatory framework highlights the NMPA's oversight in ensuring medical device safety and quality. The required action is a voluntary recall of affected knee joint components to prevent potential patient harm from incorrect component identification.